1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with am-356 in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (am-356) | Trials (am-356) | Recent Studies (post-2010) (am-356) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 216 | 0 | 42 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | am-356 (IC50) |
|---|---|---|---|
| Potassium channel subfamily K member 3 | Homo sapiens (human) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbuti, A; Feinmark, SJ; Ishii, S; Robinson, RB; Shimizu, T | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and am-356
| Article | Year |
|---|---|
Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor.
Topics: Action Potentials; Animals; Arachidonic Acids; Arrhythmias, Cardiac; Barium; Electric Conductivity; Electrophysiology; Enzyme Inhibitors; Heart; Heart Ventricles; Membrane Potentials; Mice; Mice, Knockout; Nerve Tissue Proteins; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Tandem Pore Domain; Protein Kinase C; Protons; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Zinc | 2002 |